公开(公告)号：US5601905A

公开(公告)日：1997-02-11

申请号：US395516

申请日：1995-02-27

申请人： Hisashi Watanabe ,  Takashi Tanaka ,  Kaoru Okamoto ,  Keiji Yoshizawa ,  Hiroyuki Chinju ,  Isamu Takarabe

发明人： Hisashi Watanabe ,  Takashi Tanaka ,  Kaoru Okamoto ,  Keiji Yoshizawa ,  Hiroyuki Chinju ,  Isamu Takarabe

IPC分类号： G03F7/09 ,  H05K3/28 ,  B32B7/02 ,  B32B27/08 ,  C08G73/10

CPC分类号： G03F7/094 ,  H05K3/28 ,  H05K2201/0154 ,  H05K2201/0166 ,  H05K2203/0582 ,  H05K2203/0585 ,  H05K2203/066 ,  Y10S428/901 ,  Y10T428/2495 ,  Y10T428/24967 ,  Y10T428/26 ,  Y10T428/2839 ,  Y10T428/31721

摘要： A laminate comprising at least two layers of a photosensitive resin layer and a polyimide precursor resin layer; a process for formation of an insulating protective layer using a laminate which comprises laminating a laminate comprising at least photosensitive resin layer and a polyimide precursor resin layer on an insulating board having an exposed circuit; selectively exposing the photosensitive resin layer to active light; developing the resultant photosensitive resin layer; removing the exposed polyimide precursor resin layer by etching it with an alkaline solution using the photosensitive resin layer as a mask; removing the photosensitive resin layer; and then curing the residual polyimide precusor resin layer; and a process for preparation of a printed circuit which comprises forming a polymide precursor resin layer on an insulating board having an exposed circuit, patterning the resin layer with an alkaline solution, and then curing it.The laminate of this invention can provide extremely easily an insulating protective layer for circuits having a high processing precision and excellent in reliability on insulation. Further, a printed circuit having a high processing precision and excellent in reliability on insulation can be provided extremely easily by the processes of this invention.

摘要翻译： 包含至少两层感光性树脂层和聚酰亚胺前体树脂层的层压体; 使用层压体形成绝缘保护层的方法，该方法包括在具有暴露电路的绝缘板上层叠至少包含感光性树脂层和聚酰亚胺前体树脂层的层压体; 将感光性树脂层选择性曝光为活性光; 显影所得的感光性树脂层; 通过使用感光性树脂层作为掩模，用碱性溶液蚀刻曝光的聚酰亚胺前体树脂层; 去除感光性树脂层; 然后固化残留的聚酰亚胺前体树脂层; 以及制造印刷电路的方法，包括在具有暴露电路的绝缘板上形成聚酰亚胺前体树脂层，用碱溶液对树脂层进行图案化，然后固化。 本发明的层叠体可以非常容易地提供具有高加工精度和绝缘可靠性优异的电路的绝缘保护层。 此外，通过本发明的方法，可以非常容易地提供具有高加工精度和绝缘可靠性优异的印刷电路。

公开(公告)号：US07848200B2

公开(公告)日：2010-12-07

申请号：US11624862

申请日：2007-01-19

申请人： Kaoru Okamoto ,  Jun Sumioka ,  Masakuni Yamamoto

发明人： Kaoru Okamoto ,  Jun Sumioka ,  Masakuni Yamamoto

IPC分类号： G11B20/10 ,  G11B27/36 ,  G11B5/09

CPC分类号： G11B20/20 ,  G11B20/10009

摘要： A method of reproducing multilevel information using a light spot. The multilevel information is recorded by defining virtual cells at regular intervals on tracks of an optical information recording medium and varying sizes of information pits in the cells. The method includes the steps of obtaining cell boundary values, each of the cell boundary values being obtained by performing sampling when the center of the light spot reaches a boundary between adjacent cells, calculating cell boundary value metrics on the basis of the cell boundary values and prestored reference values for the cell boundary values, calculating path metrics on the basis of the cell boundary value metrics, selecting a path metric having a minimum value of the path metrics, and reproducing the multilevel information on the basis of the path metric having the minimum value of the path metrics.

摘要翻译： 使用光点再现多级信息的方法。 通过在光信息记录介质的轨道上以规则的间隔定义虚拟单元并且在单元中定义不同大小的信息凹坑来记录多级信息。 该方法包括以下步骤：获得单元格边界值，每个单元格边界值是通过当光点的中心到达相邻单元格之间的边界时执行采样而获得的，基于单元边界值计算单元边界值度量;以及 预先存储的单元边界值的参考值，基于单元边界值度量计算路径度量，选择具有路径度量的最小值的路径度量，以及基于具有最小值的路径度量再现多级信息 路径度量的值。

公开(公告)号：US20090270634A1

公开(公告)日：2009-10-29

申请号：US12498967

申请日：2009-07-07

申请人： Kaoru Okamoto ,  Naoharu Nishimura ,  Akira Ishii

发明人： Kaoru Okamoto ,  Naoharu Nishimura ,  Akira Ishii

IPC分类号： C07D233/72

CPC分类号： C07D233/72

摘要： Conventional I-form crystals of 5-hydroxy-1-methylhydantoin contain, remaining therein in a considerable amount, the organic solvent used in a purification step. In contrast, in II-form crystals, the amount of the organic solvent remaining therein is smaller than the detection limit. Namely, the II-form crystals contain substantially no residual organic solvent. The novel II-form crystals of 5-hydroxy-1-methylhydantoin obtained through recrystallization from water not only contain substantially no residual organic solvent, but also have a high bulk density and are hence advantageous for pharmaceutical preparation. They further have properties advantageous for production, such as low adhesion. The crystals are significantly useful as a material for medicines required to have high safety, such as drugs for renal insufficiency.

摘要翻译： 常规的5-羟基-1-甲基乙内酰脲的I型晶体在其中保留相当量的纯化步骤中使用的有机溶剂。 相反，在II型晶体中，其中残留的有机溶剂的量小于检测限。 即，II型晶体基本上不含残留的有机溶剂。 通过从水中重结晶获得的5-羟基-1-甲基乙内酰脲的新型II型晶体不仅基本上不含有残留的有机溶剂，而且还具有高堆积密度，因此对于药物制剂是有利的。 它们还具有有利于生产的性质，例如低粘附性。 该晶体作为具有高度安全性的药物的材料，例如用于肾功能不全的药物是显着有用的。

公开(公告)号：US20080013582A1

公开(公告)日：2008-01-17

申请号：US11708135

申请日：2007-02-20

申请人： Kaoru Okamoto ,  Ryu Washino ,  Kazuhiro Komatsu ,  Yasushi Sakuma

发明人： Kaoru Okamoto ,  Ryu Washino ,  Kazuhiro Komatsu ,  Yasushi Sakuma

IPC分类号： H01S5/026 ,  H01L33/00

CPC分类号： H01S5/12 ,  B82Y20/00 ,  H01S5/1231 ,  H01S5/125 ,  H01S5/34306 ,  H01S5/34313

摘要： A method of manufacturing semiconductor laser device capable of reducing κL, with manufacturing restrictions satisfied, is provided. In a distributed-feedback or distributed-reflective semiconductor laser device, immediately before burying regrowth of a diffraction grating, halogen-based gas is introduced to a reactor, and etching is performed on the diffraction grating so that each side wall has at least two or more crystal faces and a ratio of length of an upper side in a waveguide direction to a bottom side parallel to a (100) surface is 0 to 0.3. And, a reactive product formed on side surfaces of the diffraction grating and in trench portions between stripes of the diffraction grating at an increase of temperature for regrowth is removed. Therefore, the diffraction grating with reduced height and a sine wave shape is obtained, thereby κL of the device is reduced. Thus, an oscillation threshold and optical output efficiency can be improved.

摘要翻译： 提供了一种制造能够减少kappa的半导体激光装置的方法，其制造限制被满足。 在分布反馈或分布反射半导体激光器件中，在埋入衍射光栅的再生长之前，将卤素基气体引入反应器，并在衍射光栅上进行蚀刻，使得每个侧壁具有至少两个或 更多的晶面和波导方向的上侧与平行于（100）面的底面的长度的比率为0〜0.3。 并且，在再生长温度升高时，衍射光栅的侧面和衍射光栅的条纹之间的沟槽部分中形成的反应产物被去除。 因此，获得具有降低的高度和正弦波形的衍射光栅，从而减小了器件的κ。 因此，可以提高振荡阈值和光输出效率。

公开(公告)号：US20070171800A1

公开(公告)日：2007-07-26

申请号：US11624862

申请日：2007-01-19

申请人： Kaoru Okamoto ,  Jun Sumioka ,  Masakuni Yamamoto

发明人： Kaoru Okamoto ,  Jun Sumioka ,  Masakuni Yamamoto

IPC分类号： G11B20/10

CPC分类号： G11B20/20 ,  G11B20/10009

摘要： In a method of reproducing multilevel information, cell-boundary values are obtained. Each of the cell-boundary values is obtained when the center of a light spot comes at a boundary between adjacent cells. Then, on the basis of the cell-boundary values and prestored reference values for the cell-boundary value, cell-boundary-value metrics are calculated. Furthermore, on the basis of the cell-boundary-value metrics, path metrics are calculated.

摘要翻译： 在再现多级信息的方法中，获得了单元格边界值。 当光点的中心位于相邻单元之间的边界时，获得每个单元格边界值。 然后，基于小区边界值和小区边界值的预存储参考值，计算小区边界值度量。 此外，基于小区边界值度量，计算路径度量。

公开(公告)号：US20060222032A1

公开(公告)日：2006-10-05

申请号：US11215122

申请日：2005-08-31

申请人： Yasushi Sakuma ,  Katsuya Motoda ,  Kaoru Okamoto ,  Ryu Washino

发明人： Yasushi Sakuma ,  Katsuya Motoda ,  Kaoru Okamoto ,  Ryu Washino

IPC分类号： H01S5/00

CPC分类号： H01S5/12 ,  H01S5/227 ,  H01S5/30

摘要： An InGaAsP thin film layer having the same index of refraction as a diffraction grating is inserted between a p-type InP clad layer and the diffraction grating composed of an InGaAsP layer. In this structure, the InGaAsP layer is present over an active layer, and the amount of thermal diffusion of dopant to the vicinity of the active layer does not depend on an aperture width or the presence or absence of the diffraction grating when the p-type InP clad layer is grown, thereby obtaining a stable optical output, a threshold current, and slope efficiency.

摘要翻译： 将具有与衍射光栅相同折射率的InGaAsP薄膜层插入p型InP包层和由InGaAsP层构成的衍射光栅之间。 在该结构中，InGaAsP层存在于有源层上，并且掺杂剂到有源层附近的热扩散量不依赖于孔径宽度或衍射光栅的存在或不存在，当p型 生长InP覆层，从而获得稳定的光输出，阈值电流和斜率效率。

公开(公告)号：US5658918A

公开(公告)日：1997-08-19

申请号：US409054

申请日：1995-03-23

申请人： Kaoru Okamoto ,  Taisuke Hasegawa ,  Akio Namimatsu

发明人： Kaoru Okamoto ,  Taisuke Hasegawa ,  Akio Namimatsu

IPC分类号： A61K31/52 ,  A61K31/522 ,  A61P11/02 ,  A61P27/16 ,  C07D473/28

CPC分类号： C07D473/28

摘要： The present invention provides purine derivatives and pharmaceutically acceptable salts thereof which exhibit an inhibitory action towards nasal mucus secretion and are useful as pharmaceuticals for treatment of nasal secretion and rhinitis. The purine derivatives are represented by the following general formula: ##STR1## wherein R is alkyl or cycloalkyl, or optionally-substituted phenyl or phenylalkyl; R' is hydrogen or --COOX; and X is alkyl, alkenyl, alkoxyalkyl, phenyl or phenylalkyl. The compounds are useful as therapeutic and preventive agents for various types of rhinitis accompanied by acceleration of nasal mucus secretion and by the sneezing reflex such as allergic rhinitis. The compounds may be administered orally and exhibit low toxicity, little side effect and high safety. Accordingly, continuous long term administration of the pharmaceutical compositions may be performed for highly effective treatment of rhinitis.

摘要翻译： 本发明提供嘌呤衍生物及其药学上可接受的盐，其对鼻粘液分泌具有抑制作用，并且可用作治疗鼻分泌和鼻炎的药物。 嘌呤衍生物由以下通式表示：其中R是烷基或环烷基或任选取代的苯基或苯基烷基; R'是氢或-COOX; X是烷基，烯基，烷氧基烷基，苯基或苯基烷基。 这些化合物可用作各种类型的鼻炎的治疗和预防剂，伴随着加速鼻粘液分泌和喷鼻反射如过敏性鼻炎。 化合物可以口服给药，毒性低，副作用小，安全性高。 因此，可以进行药物组合物的连续长期给药以高效治疗鼻炎。

公开(公告)号：US5438125A

公开(公告)日：1995-08-01

申请号：US845665

申请日：1992-03-04

申请人： Kaoru Okamoto ,  Shinji Morita

发明人： Kaoru Okamoto ,  Shinji Morita

IPC分类号： C07H3/04 ,  C07H13/04 ,  C07H15/04 ,  C07H15/10 ,  C07H19/06 ,  C07H19/16 ,  C07J41/00 ,  C07H15/00 ,  C07H15/24 ,  C08B37/00

CPC分类号： C07H13/04 ,  C07H15/04 ,  C07H15/10 ,  C07H19/06 ,  C07H19/16 ,  C07H3/04 ,  C07J41/0055

摘要： Sialic acid compounds of formula ##STR1## wherein X is hydrogen, a lower alkyl group or benzyl, Y is hydrogen or acetyl, Ac is acetyl, and the wavy line represents that the compound of the formula (I) includes both a .alpha.-anomer and .beta.-anomer, have excellent chemical and enzymatical stability and are useful in the treatment of central or peripheral nervous diseases.

摘要翻译： 式（I）的唾液酸化合物其中X是氢，低级烷基或苄基，Y是氢或乙酰基，Ac是乙酰基，波浪线表示式（I）的化合物包括 α-异头物和β-戊内酯，具有极好的化学和酶学稳定性，可用于治疗中枢性或周围神经疾病。

公开(公告)号：US08643570B2

公开(公告)日：2014-02-04

申请号：US12145673

申请日：2008-06-25

申请人： Kaoru Okamoto ,  Tadahiko Hirai ,  Jun Sumioka

发明人： Kaoru Okamoto ,  Tadahiko Hirai ,  Jun Sumioka

IPC分类号： G09G3/30

CPC分类号： G09G3/3241 ,  G09G3/2014 ,  G09G2300/0842 ,  G09G2310/0251 ,  G09G2310/0262

摘要： An active matrix organic electroluminescence(EL) display comprises plural selection and data lines mutually crossed, and a pixel circuit connected to the selection and data lines and having switching devices, a storage capacitor and an organic EL device. In a part of a period that the pixel circuit connected to the selection line is being selected, an applied first data signal is held as a voltage at the storage capacitor of the selected pixel circuit. After the selection signal applying, a first current according to the held voltage is supplied to the organic EL device, and this emits light at luminance according to the first current. In another part of the period, a second current according to an applied second data signal is supplied to the organic EL device of the selected pixel circuit, and this emits light at luminance according to the second current.

摘要翻译： 有源矩阵有机电致发光（EL）显示器包括相互交叉的多个选择和数据线，以及连接到选择和数据线并具有开关器件，存储电容器和有机EL器件的像素电路。 在选择与选择线连接的像素电路的期间的一部分中，施加的第一数据信号作为所选像素电路的存储电容器的电压被保持。 在选择信号施加之后，根据保持电压的第一电流被提供给有机EL器件，并且根据第一电流发光。 在该周期的另一部分中，根据所施加的第二数据信号的第二电流被提供给所选择的像素电路的有机EL器件，并且根据第二电流发光。

公开(公告)号：US07858806B2

公开(公告)日：2010-12-28

申请号：US12498967

申请日：2009-07-07

申请人： Kaoru Okamoto ,  Naoharu Nishimura ,  Akira Ishii

发明人： Kaoru Okamoto ,  Naoharu Nishimura ,  Akira Ishii

IPC分类号： C07D233/80

CPC分类号： C07D233/72

摘要： Conventional I-form crystals of 5-hydroxy-1-methylhydantoin contain, remaining therein in a considerable amount, the organic solvent used in a purification step. In contrast, in II-form crystals, the amount of the organic solvent remaining therein is smaller than the detection limit. Namely, the II-form crystals contain substantially no residual organic solvent. The novel II-form crystals of 5-hydroxy-1-methylhydantoin obtained through recrystallization from water not only contain substantially no residual organic solvent, but also have a high bulk density and are hence advantageous for pharmaceutical preparation. They further have properties advantageous for production, such as low adhesion. The crystals are significantly useful as a material for medicines required to have high safety, such as drugs for renal insufficiency.

摘要翻译： 常规的5-羟基-1-甲基乙内酰脲的I型晶体在其中保留相当量的纯化步骤中使用的有机溶剂。 相反，在II型晶体中，其中残留的有机溶剂的量小于检测限。 即，II型晶体基本上不含残留的有机溶剂。 通过从水中重结晶获得的5-羟基-1-甲基乙内酰脲的新型II型晶体不仅基本上不含有残留的有机溶剂，而且还具有高的堆积密度，因此对于药物制剂是有利的。 它们还具有有利于生产的性质，例如低粘附性。 该晶体作为具有高度安全性的药物的材料，例如用于肾功能不全的药物是显着有用的。